文章预览
报告详情 报告人：Pro f. Edward W. Tate Imperial College London 注：本次报告为线下报告。 时间： 2024年9月20日(星期五)14:00 地点： 北京大学化学与分子工程学院百廿纪念报告厅（A204） 主请人：王初 报告摘要 From novel antimalarials to next generation Antibody-Drug Conjugate payloads The Tate lab develops novel chemical biology approaches to enable drug discovery against post-translational modification (PTM) pathways and intractable drug targets, including chemical proteomic target identification, screening technologies, and chemical probe discovery for protein-protein interactions and enzymes modulating PTMs. Recent highlights include the first cell-active activity-based probes (ABPs) for deubiquitinases (DUBs), new tools for analysis and discovery of pathogenic secreted protease activities, and the first comprehensive maps of specific classes of pro
………………………………
